Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Adenocarcinoma and AKT2[original query] |
---|
AKT1 and AKT2 mutations in lung cancer in a Japanese population. Molecular medicine reports 0 1 (5): 663-6. Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita |
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71. Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife |
Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 2014 Dec 147 (6): 1350-62.e4. Liang Qiaoyi, Yao Xiaotian, Tang Senwei, Zhang Jingwan, Yau Tung On, Li Xiaoxing, Tang Ceen-Ming, Kang Wei, Lung Raymond W M, Li Jing Woei, Chan Ting Fung, Xing Rui, Lu Youyong, Lo Kwok Wai, Wong Nathalie, To Ka Fai, Yu Chang, Chan Francis K L, Sung Joseph J Y, Yu J |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients. Oncotarget 2016 Feb . Wu Shang-Gin, Liu Yi-Nan, Tsai Meng-Feng, Chang Yih-Leong, Yu Chong-Jen, Yang Pan-Chyr, Yang James Chih-Hsin, Wen Yueh-Feng, Shih Jin-Yu |
Short-Term Responders of Non-Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms. Translational oncology 2018 9 11 (6): 1364-1369. Xu Yanjun, Tong Xiaoling, Yan Junrong, Wu Xue, Shao Yang W, Fan Y |
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion. Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 28, 2024
- Content source: